Recap: Beam Therapeutics Q4 Earnings

Beam Therapeutics BEAM reported its Q4 earnings results on Tuesday, February 27, 2024 at 06:30 AM.

Here's what investors need to know about the announcement.

Beam Therapeutics beat estimated earnings by 271.0%, reporting an EPS of $1.73 versus an estimate of $-1.01.

Revenue was up $296.15 million from the same period last year.

Last quarter the company beat on EPS by $0.12 which was followed by a 3.0% drop in the share price the next day.

Here's a look at Beam Therapeutics's past performance:

Quarter	Q3 2023	Q2 2023	Q1 2023	Q4 2022
EPS Estimate	-1.34	-1.42	-1.34	-1.33
EPS Actual	-1.22	-1.08	-1.33	-0.54
Revenue Estimate	17.49M	18.05M	14.08M	12.53M
Revenue Actual	17.19M	20.12M	24.21M	20.04M

To track all earnings releases for Beam Therapeutics visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings Calendar